Pavlov George 4
4 · MapLight Therapeutics, Inc. · Filed Feb 20, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) Director Pavlov George Buys Shares
What Happened Pavlov George, a director of MapLight Therapeutics, acquired a total of 25,000 common shares in open‑market purchases between Feb 18–20, 2026, for an aggregate cost of approximately $441,168. The purchases were reported as follows: 10,658 shares on 2026‑02‑18 at a $17.48 weighted average ($186,302); 4,422 shares on 2026‑02‑19 at a $17.57 weighted average ($77,695); and 9,920 shares on 2026‑02‑20 at a $17.86 weighted average ($177,171). These were purchases (transaction code P), which investors often view as a more informative signal than routine sales.
Key Details
- Transaction dates and weighted-average prices:
- 2026‑02‑18: 10,658 shares @ $17.48 (WA) — $186,302. (F1: prices in this block ranged $17.22–$17.72)
- 2026‑02‑19: 4,422 shares @ $17.57 (WA) — $77,695. (F2: prices in this block ranged $17.28–$17.75)
- 2026‑02‑20: 9,920 shares @ $17.86 (WA) — $177,171. (F3: prices in this block ranged $17.74–$17.95)
- Total: 25,000 shares acquired for ~$441,168.
- Shares owned after transaction: not disclosed in the provided excerpt of the Form 4 — see the full filing for post‑transaction holdings.
- Footnotes: Each reported price is a weighted average; the filing commits to provide per‑trade price breakdowns on request (see F1–F3 for ranges).
- Filing info/timeliness: Form filed 2026‑02‑20 reporting purchases through 2026‑02‑20; no indication in this excerpt that the filing was late.
Context These were straight open‑market purchases by a company director (not an option exercise, gift, or 10% owner disclosure in this excerpt). Director purchases can be of interest to retail investors as a data point on insider accumulation, but they do not by themselves indicate future performance or motives. For full details (exact per‑trade prices, post‑transaction holdings, and any related disclosures) consult the complete Form 4 (Accession No. 0001470798-26-000002).
Insider Transaction Report
- Purchase
Voting Common Stock
[F1]2026-02-18$17.48/sh+10,658$186,302→ 10,658 total - Purchase
Voting Common Stock
[F2]2026-02-19$17.57/sh+4,422$77,695→ 15,080 total - Purchase
Voting Common Stock
[F3]2026-02-20$17.86/sh+9,920$177,171→ 25,000 total
Footnotes (3)
- [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.22 to $17.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.28 to $17.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.74 to $17.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.